NRL Pharma Inc.
Basic information
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
BB Laboratories Inc.
|
||||||||
|
Sohiken Holdings Co., Ltd.
|
||||||||
|
General Medical Science Research Institute Inc.
|
Network
History
1998 : Founded by Tamura Gakuzo, Ando Kunio, and others as Nuclear Receptor Research Institute Co., Ltd.![]()
2000 : Developed enteric-coated lactoferrin and began selling it as a health supplement (supplement).![]()
Discovery of lactoferrin’s lipid metabolism improvement effect through joint research with Tottori University.![]()
2001 : Discovered lactoferrin's lipid metabolism improvement effect through joint research with Tottori University.![]()
Discovery of lactoferrin’s analgesic and anxiolytic effects through joint research with Tottori University.![]()
2002 : Discovered lactoferrin's analgesic and anxiolytic effects through joint research with Tottori University.![]()
Discovery of lactoferrin’s heavy metal damage improvement effect through joint development with Jikeikai Medical University.![]()
2005 : Discovered "Lactoferrin's heavy metal damage improvement effect" through joint development with Jikeikai Medical University.![]()
Obtained a patent for "frequent urination improvement agents and compositions containing them, including pharmaceuticals and foods".![]()
2008: Patent obtained for "Antidiuretic agent and pharmaceutical compositions and foods containing it."![]()
License granted to a company for a lipid metabolism‑improving composition and lactoferrin enteric‑coated processing technology patent.![]()
2009: Licensed the rights to a lipid metabolism improvement composition and lactoferrin enteric processing technology patent to a company.![]()
Selected for the 2010 Industrial Property Utilization Excellence Award (Minister of Economy, Trade and Industry).![]()
Received the Innovation Encouragement Award from the Innovation Association at the 2010 Kanto Regional Innovation Awards.![]()
Obtained a Japanese patent for Lactoferrin "Method and Use for Producing a New Food that Improves Quality of Life (Enteric Coating)."![]()
Obtained a patent for Ascochlorin "New Transcription Factor, Its Production Method and Use (Acetylated Derivative)."![]()
2010: Selected as an excellent enterprise for utilizing industrial property rights in fiscal 2010 by the Minister of Economy, Trade and Industry (Patent Utilization Excellence Award).![]()
2010: Received the Innovation Encouragement Award from the Japan Innovation Association at the Kanto Regional Innovation Awards.![]()
2010: Japanese patent obtained for "Method of manufacturing and use of lactoferrin for improving quality of life (enteric-coated agent)."![]()
2010: Patent obtained for "Ascorclorin new transcription factor, its method of manufacture and use (acetylated derivative)."![]()
Obtained a patent for Ascochlorin "New Transcription Factor, Its Production Method and Use (Imine Derivative)."![]()
2011: Patent obtained for "Ascorclorin new transcription factor, its method of manufacture and use (imino derivative)."![]()
Received the Agricultural and Chemical Technology Award jointly with Lion Corporation from the Japan Society of Agricultural and Biological Chemistry for developing a lactoferrin‑containing functional food focusing on enteric processing technology.![]()
Obtained a patent for Lactoferrin "New Pharmaceutical Composition for Treating or Preventing Dry Eye and Processed Food."![]()
Obtained a patent for "Pharmaceutical Composition and Processed Food Containing Lactoferrin (Menstrual Pain Relief Effect)."![]()
2012: Awarded the Japan Agricultural and Chemical Society Agricultural and Chemical Technology Award jointly with Lion Corporation for developing a lactoferrin-containing functional food focusing on enteric processing technology.![]()
2012: Patent obtained for "novel pharmaceutical compositions and processed foods containing lactoferrin for the treatment or prevention of dry eye."![]()
2012: Patent obtained for "pharmaceutical compositions containing lactoferrin and processed foods (menstrual pain relief effect)."![]()
2015: Patent obtained for "lactoferrin fusion proteins and their manufacturing methods (Fc-LF fusion)."![]()
Obtained a patent for Lactoferrin "Pharmaceutical Composition and Food for Improving Menopause Disorders."![]()
2016: Patent obtained for "pharmaceutical compositions and food products for improving menopausal disorders containing lactoferrin."![]()
Astaxanthin Preparation, Eye Focus Adjustment Supplement "HAEMATOP" (Functional Claim Receipt) Launch.![]()
2017: Launch of Oral Care Chewable Series products "Lactoferrin Oral Wet" and "Lactoferrin Oral Periblock."![]()
2017: Launch of astaxanthin formulation, eye focus adjustment supplement "HAEMATOP" (functional food notification received).![]()
News
There is no news.